🌱 Longevity 🟠 Preliminary Evidence

Epithalon

Last reviewed: June 2026

A synthetic tetrapeptide derived from a pineal gland extract, studied for decades in Russian gerontology research for telomerase activation and potential life-extension effects.

Not FDA approved for human use in most jurisdictions. For research purposes only.

FDA Advisory Panel Review -- July 23-24, 2026

This peptide is scheduled for review by the FDA Pharmacy Compounding Advisory Committee (PCAC) to evaluate inclusion on the 503A Bulks List. This is a regulatory review process, not an approval decision. Research and educational context only.

Beginner Summary

What it is: A four-amino-acid synthetic peptide derived from pineal gland research, studied for its potential to activate telomerase, lengthen telomeres, and support longevity markers.

Research suggests: Russian institutional studies spanning several decades report telomere lengthening, improved immune markers, and extended lifespan in preclinical studies and some human studies.

Best for: Longevity and anti-aging researchers

Key thing to know: The evidence base is real but narrow - most human data comes from a single Russian research institution and has not been independently replicated at scale.

What is Epithalon?

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide , just four amino acids (Ala-Glu-Asp-Gly) , derived from Epithalamin, a natural polypeptide extract from the bovine pineal gland. It was developed and studied extensively by the St. Petersburg Institute of Bioregulation and Gerontology in Russia, where it has been researched for several decades as part of a broader program on peptide bioregulators and their effects on aging and longevity.

Researchers have studied Epithalon for telomere elongation, telomerase activation, antioxidant activity, circadian rhythm regulation via melatonin modulation, and potential life extension effects , primarily in preclinical studies with some limited human studies in aging populations. It is one of the most extensively studied compounds within the Russian peptide bioregulator research tradition.

How it works.

Telomeres are the protective caps at the ends of chromosomes , think of them like the plastic tips on shoelaces that prevent the lace from fraying. Every time a cell divides, telomeres get slightly shorter. When they become too short, the cell can no longer divide properly and enters a dysfunctional state associated with cellular aging and tissue decline.

Telomerase is the enzyme that can rebuild and lengthen telomeres, but its activity declines significantly with age in most cell types.

Epithalon research suggests it may activate telomerase expression in cells, potentially slowing or partially reversing the telomere shortening process. Studies indicate it upregulates telomerase activity in human fetal fibroblasts and other cell lines. This mechanism is scientifically plausible , telomere maintenance is a well-established component of cellular longevity biology , but its translation to meaningful longevity effects in healthy humans has not been established in large trials.

It is also studied for its effects on the pineal gland and melatonin production. Melatonin regulates circadian rhythms and declines significantly with age; research suggests Epithalon may support pineal function and melatonin synthesis, which has its own antioxidant and chronobiological significance in the aging literature.

What the research shows.

🟠 Preliminary Evidence

Epithalon research comes primarily from Russian institutional studies , a body of work that is real, peer-reviewed, and published in scientific literature, but conducted largely outside the large-scale randomized controlled trial framework standard in Western clinical research. Preclinical studies show lifespan extension in fruit flies and rodents, preservation of telomere length, and antioxidant effects. These findings have been consistent within the research group.

Limited human studies from the same Russian research institution report improvements in melatonin levels, sleep quality, immune markers, and general indicators of biological aging in elderly populations. These are genuine research findings, but they come from a single research group and have not been independently replicated by Western research teams in large-scale trials.

The biological mechanism is scientifically credible , telomerase activation as a longevity strategy is taken seriously in mainstream aging research , but the specific evidence for Epithalon in humans remains narrow. This creates an interesting situation: more research exists for this compound than for many newer peptides, but the research architecture differs from the RCT-centered standards used to establish Strong or Moderate evidence in Western medicine.

Evidence rating: Preliminary , Genuine but narrow research base, primarily from Russian institutional studies. Human data exists but is limited and has not been independently replicated at scale in Western research.

Biomarkers to review first.

Research protocols for Epithalon typically reference the following biomarkers as baseline context. Testing these before exploring this peptide gives you and your healthcare provider the most relevant starting information.

What it's commonly researched with.

Epithalon appears in longevity and cellular aging research protocols alongside other compounds targeting mitochondrial function, NAD+ metabolism, and GH axis optimization. The combinations below reflect what appears in research literature , not recommendations for use without clinical supervision.

Goals & biomarkers connected to this peptide.

Ready to explore further?

Use the Peptide Finder to see how Epithalon fits your biology profile, or browse the full library.

For educational and research purposes only. Not medical advice. Always consult a licensed healthcare provider before making any health decisions.